Natalizumab for multiple sclerosis: A complicated treatment

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)677-678
Number of pages2
JournalThe Lancet Neurology
Volume10
Issue number8
DOIs
StatePublished - Aug 2011

Fingerprint

Progressive Multifocal Leukoencephalopathy
Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
Monoclonal Antibodies
Natalizumab

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Natalizumab for multiple sclerosis : A complicated treatment. / Keegan, B. Mark.

In: The Lancet Neurology, Vol. 10, No. 8, 08.2011, p. 677-678.

Research output: Contribution to journalArticle

@article{cb5d14cb77434935bc082b9bfed83b17,
title = "Natalizumab for multiple sclerosis: A complicated treatment",
author = "Keegan, {B. Mark}",
year = "2011",
month = "8",
doi = "10.1016/S1474-4422(11)70150-8",
language = "English (US)",
volume = "10",
pages = "677--678",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "8",

}

TY - JOUR

T1 - Natalizumab for multiple sclerosis

T2 - A complicated treatment

AU - Keegan, B. Mark

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=79960364322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960364322&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(11)70150-8

DO - 10.1016/S1474-4422(11)70150-8

M3 - Article

C2 - 21777819

AN - SCOPUS:79960364322

VL - 10

SP - 677

EP - 678

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 8

ER -